SCHEMBL26398697

SCHEMBL26398697

CC(C)NCCNCCNCCN1CCNCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 1/20 0.45
ERAP2 Q6P179 1/20 0.45
RAD52 P43351 1/20 0.45
HSD17B10 Q99714 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CHRM5 P08912 1/20 0.41
CHRM3 P20309 1/20 0.41
ALDH1A1 P00352 3/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
RECQL P46063 1/20 0.41
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CXCR4 P61073 2/20 0.39
ACE2 Q9BYF1 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13185218 0.89 RAD52 (0.50) ANPEPERAP2RAD52HSD17B10CYP3A4
SCHEMBL8520829 0.86 ANPEP (0.50) ANPEPERAP2RAD52HSD17B10CYP3A4
SCHEMBL25566219 0.85 ACE2 (0.48) ALDH1A1MEN1KMT2ARECQLACE2
SCHEMBL29860764 0.84 HSD17B10 (0.55) ANPEPERAP2RAD52HSD17B10CYP3A4
SCHEMBL845511 0.82 HSD17B10 (0.57) ANPEPERAP2RAD52HSD17B10CYP3A4
SCHEMBL10035773 0.81 CXCR4 (0.50) ANPEPERAP2RAD52HSD17B10CYP3A4
SCHEMBL18427337 0.79 CARM1 (0.48) ANPEPERAP2RAD52HSD17B10CYP3A4
SCHEMBL13078379 0.79 HSD17B10 (0.47) ANPEPERAP2RAD52HSD17B10CYP3A4
SCHEMBL25568895 0.79 CARM1 (0.48) ANPEPERAP2RAD52HSD17B10CYP3A4
SCHEMBL14980614 0.79 HSD17B10 (0.47) ANPEPERAP2RAD52HSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250205639-A1 CARBON DIOXIDE SEPARATOR, AND METHOD FOR SEPARATING OR RECOVERING CARBON DIOXIDE RESEARCH INSTITUTE OF INNOVATIVE TECHNOLOGY FOR THE EARTH (JP) 2025-06-26 US disclosed
WO-2023181676-A1 CARBON DIOXIDE SEPARATOR, AND METHOD FOR SEPARATING OR RECOVERING CARBON DIOXIDE 公益財団法人地球環境産業技術研究機構 2023-09-28 WO disclosed
WO-2023181676-A1 CARBON DIOXIDE SEPARATOR, AND METHOD FOR SEPARATING OR RECOVERING CARBON DIOXIDE 公益財団法人地球環境産業技術研究機構 2023-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250205639-A1 CARBON DIOXIDE SEPARATOR, AND METHOD FOR SEPARATING OR RECOVERING CARBON DIOXIDE SIGMAR1, CHRM1, GRM1 ANPEP 2801/4885ERAP2 1828/4885RAD52 738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.